Q2 2016

Filed Aug 9, 2016 · 10-Q · 40 days after period end · 0001144204-16-117776

Q2 2016 · 10-Q

Revenue

$157.00K

−59.8% vs Q2 2015

Net Income

-$14.18M

N/M vs Q2 2015

EPS Diluted

-$0.16

N/M vs Q2 2015

Operating Income-$15,023,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2016	Q2 2015	Q2 2014	Q2 2013
Revenue	$157.00K	$391.00K	$0.00	$272.00K
Net Income	-$14.18M	-$66.85M	-$25.87M	-$11.59M
EPS Diluted	-$0.16	-$0.88	-$0.45	-$0.40

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR